ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,464.62
-0.16%
US Tech 100
19,220.00
-0.20%
다우존스 지수
39,150.33
0.04%
Bitcoin
64,455.89
0.33%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAFW)

  7. bioAffinity Technologies Inc (BIAFW) 뉴스

BIAFW

bioAffinity Technologies (BIAFW)

bioAffinity Technologies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BIAFW
일자시간출처헤드라인심볼기업
2024/06/1509:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
2024/06/1509:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
2024/06/1509:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
2024/06/1221:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFWbioAffinity Technologies Inc
2024/06/0605:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIAFWbioAffinity Technologies Inc
2024/06/0605:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFWbioAffinity Technologies Inc
2024/05/2305:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
2024/05/2305:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
2024/05/1523:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFWbioAffinity Technologies Inc
2024/05/1522:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFWbioAffinity Technologies Inc
2024/05/0221:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
2024/04/2421:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFWbioAffinity Technologies Inc
2024/04/0921:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFWbioAffinity Technologies Inc
2024/04/0122:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
2024/03/0902:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
2024/03/0623:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
2024/02/2122:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
2024/01/3022:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFWbioAffinity Technologies Inc
2024/01/0822:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFWbioAffinity Technologies Inc
2023/12/0522:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFWbioAffinity Technologies Inc
2023/11/3022:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFWbioAffinity Technologies Inc
2023/11/2822:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFWbioAffinity Technologies Inc
2023/11/1506:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
2023/11/0622:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFWbioAffinity Technologies Inc
2023/10/1021:00Business WirebioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
2023/09/0721:00Business WirebioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
2023/08/1506:03Business WirebioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
2023/07/1221:00Business WireAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerNASDAQ:BIAFWbioAffinity Technologies Inc
2023/06/1521:00Business WirebioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
2023/05/2221:00Business WirebioAffinity Technologies Presents Research Findings at CYTO 2023NASDAQ:BIAFWbioAffinity Technologies Inc
 검색 관련기사 보기:NASDAQ:BIAFW

최근 히스토리

BIT
F34758
Vontobel Financial Produ...
BIT
UR9KFQ
UniCredit Bank
BIT
GBE5
ETFS 5x Short GBP Long EUR
USOTC
LRENY
Lojas Renner (PK)
EU
5002D
5002D
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유